Table 3.

Rheumatic heart disease findings on screening echo.

	CRITERIA USED	RHD ANY n, %	MITRAL REGURGITATION, n (%)	MITRAL STENOSIS (ANY), n (%)	AORTIC REGURGITATION (ANY), n (%)	AORTIC STENOSIS (ANY), n (%)
Studies using Portable or Handlehd Echocardiography
Otto 2011	WHO consensus statement 2001	Any: 16 (4.6%) Definite: 8 Nondefinite: 8	Any: 12 (3.6%) Mild: 7 Mid/Moderate: 2 Moderate: 2 Moderate/Severe: 1	0	Any: 6 (1.7%) Mild: 6	0
Beaton 2019	WHF	Any: 51 (1.5%) Mild: 31 Moderate: 14 Severe: 6	Any: 45 (1.3%) Mild: 28 Moderate: 15 Severe: 2	Any: 3 (0.1%) Mild: 2 Moderate: 1	Any: 7 (0.2%) Mild: 5 Moderate: 1 Severe: 1	0
Nascimento 2021	Adapted ASE criteria for major heart disease	Any: 12 (1.1%)*	Any: 12 (1.1%) Mild to moderate: 11 Moderate: 1	Any: 1 (0.1%) Mild: 1	Any: 3 (0.3%) Mild: 3	Any: 1 (0.1%) Mild: 1
Snelgrove 2021	WHF	Any: 3 (0.5%)	Any: 1 (0.2%) Moderate: 1	Any: 2 (0.33%) Severe: 2	Any: 1 (0.2%) Moderate: 1	0
AlSharqi 2022	ASE/EACVI recommendations	Any: 20 (6.6%)	‘mitral valve involvement’: 20 (6.6%)	Significant: 17 (5.6%)	‘aortic valve involvement’ 3 (1%)	Significant: 1 (0.3%)
Screening using standard echocardiography or nonspecified echocardiographer
Selvarani 2014	NA	Any: 17 (1.5%)	Any: 1 (0.1%)	Any: 14 (1.2%)	Any: 3 (0.03%)	NA
Bacha 2019	WHF	Significant: 9 (2.3%)	Any: 4 (1%) Moderate to Severe: 2 NS: 2	Moderate to Severe: 3 (0.8%)	Moderate to Severe: 2 (0.5%)	Moderate to Severe: 2(0.5%)
Gomathi 2019	NA	Any: 12 (4.0%)	Any: 4 (1.3%)	Any: 4 (1.3%) Moderate: 3 Not specified: 1	Any: 1 (0.3%) Not specified: 1	Any: 1 (0.3%) Not specified: 1
Bozkaya 2020	WHF	Any: 26 (2.9%)	Any 24 (2.7%) Mild: 20 Moderate: 4	Mild: 2 (0.2%)	0	0
Patel 2021	NA	61 (0.4%)	Any: not specified; ‘mitral valve involvement’: 61	Number not specified, but ‘90% were mild to moderate, and 67% had Wilkins score <8’	NA	NA

*RHD on screening was suspected in 36 women (3.2%), but only 56 of the 100 women who screened positive had a confirmatory echocardiogram.